Publication | Closed Access

NIR-II excitation self-assembly nanomedicine for targeted NIR-IIa fluorescence imaging-guided cuproptosis-promoted synergistic therapy against triple-negative breast cancer

NanomedicineDrug TargetingEngineeringTherapeutic ImagingBreast CancerNir-ii ExcitationTriple-negative Breast CancerBiomedical EngineeringTumor TargetingRadiation Oncology